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Introduction
Sarcomere assembly is a process orchestrated by the sequen-
tial expression of structural and signaling proteins, which ulti-
mately leads to the formation of mature myofi brils. It involves 
the exchange of nonmuscle myosin IIB for muscle myosin II, 
the incorporation of titin and titin-binding proteins into the na-
scent myofi bril, the lateral alignment of sarcomeric proteins, 
and the fusion of α-actinin–rich Z bodies into Z bands (Dabiri 
et al., 1997). During maturation of the sarcomere, titin’s NH2 
terminus is localized in Z bodies, and muscle myosin II is 
aligned along the developing myofi bril, presumably in a titin-
dependent process (Rhee et al., 1994). Mature myofi brils are 
characterized by the alignment of muscle myosin II fi laments 
to form A bands and the fusion of Z bodies to form Z bands 
(Tokuyasu and  Maher, 1987; Ehler et al., 1999; Sanger et al., 
2000). They contain a continuous elastic fi lament system along 
the myofi bril with titin molecules overlapping at the Z disc 
and M band, which has been regarded as a molecular ruler or 
blueprint for sarcomere assembly (Labeit and Kolmerer, 1995; 
 Trinick, 1996; van der Loop et al., 1996; Obermann et al., 1997; 
Gregorio et al., 1998).
In addition to its structural role in myofi brillogenesis, 
 titin’s M-line region has been implicated in sarcomere assembly 
through the titin kinase domain and its in vitro substrate titin 
cap (T-cap), which is also known as telethonin. Activation of 
the titin kinase and phosphorylation of T-cap in differentiating 
 myocytes has been hypothesized to be involved in  reorganization 
of the cytoskeleton during myofi brillogenesis (Mayans et al., 
1998). So far, no suitable animal or tissue culture model was 
available to test this hypothesis.
We have successfully used the Cre-lox recombination sys-
tem to excise titin’s M-line exons (MExs) 1 and 2 in striated 
muscle and demonstrated their importance in both skeletal and 
cardiac muscle (Gotthardt et al., 2003; Peng et al., 2006). Loss 
of titin’s M line leads to impaired stability of the muscle fi ber 
with the disassembly of existing sarcomeres. This results in re-
duced cardiac output followed by a failure to thrive and lethality 
dependent on the onset and level of Cre expression. The condi-
tional knockout approach enabled the generation of adult ani-
mals to study titin’s function in the mature heart and skeletal 
muscle, but expression kinetics of the Cre recombinase trans-
gene preclude the analysis of titin’s role in sarcomere assembly 
during early embryonic development. To distinguish a role in 
sarcomere assembly from a role in stabilizing preexisting sarco-
meres and to address potential nonmuscle functions, we have 
converted our conditional M-line titin knockout into a complete 
knockout using germline recombination. In this study, we show 
that titin’s M-line region is dispensable for initial sarcomere 
 assembly, including the correct localization of M-band proteins, 
but that it is required to fortify the sarcomere structure and for 
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Titin, the largest protein known to date, has been linked to sarcomere assembly and function through its elastic adaptor and signaling domains. Titin’s 
M-line region contains a unique kinase domain that has 
been proposed to regulate sarcomere assembly via its 
substrate titin cap (T-cap). In this study, we use a titin 
M line–deﬁ cient mouse to show that the initial assembly of 
the sarcomere does not depend on titin’s M-line region or 
the phosphorylation of T-cap by the titin kinase. Rather, 
 titin’s M-line region is required to form a continuous titin 
ﬁ lament and to provide mechanical stability of the embry-
onic sarcomere. Even without titin integrating into the 
M band, sarcomeres show proper spacing and alignment 
of Z discs and M bands but fail to grow laterally and ulti-
mately disassemble.
The comparison of disassembly in the developing 
and mature knockout sarcomere suggests diverse func-
tions for titin’s M line in embryonic development and the 
adult heart that not only involve the differential expression 
of titin isoforms but also of titin-binding proteins.
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lateral growth. Although the titin M line–defi cient hearts start to 
contract and loop properly, wall thickness and trabeculation are 
reduced from embryonic day (E) 9.5 followed by apoptosis sec-
ondary to the reduced cardiac output. Monitoring the localiza-
tion and embryonic expression of M-band proteins and proposed 
substrates of the titin kinase, we were able to attribute the sarco-
mere disassembly to titin’s structural functions. Unlike in the 
adult knockout sarcomere, kinase-defi cient titin does not inte-
grate into the A band and, thus, fails to form a continuous fi la-
ment system. The failure to cross-link myomesin and titin 
results in increased mobility of titin’s COOH terminus. 
These structural changes lead to reduced stability and ultimately 
to disassembly of the sarcomere.
Results
Titin deﬁ ciency leads to early 
embryonic lethality
The titin M-line region is critical for the maintenance of sarco-
mere structure and function in adult muscle (Gotthardt et al., 
2003). To address its role in early cardiac development 
and possible nonmuscle functions, we have used germline 
Figure 1. Conversion of the inducible into a constitutive titin kinase region knockout. (A) Outline of the exon/intron structure of titin’s M-line region and lo-
cation of the genotyping primers (PL1, 2, and 4) and in situ probes (prekin and kinase). Cre-mediated recombination leads to the deletion of exons 358 
and 359 (MEx1 and 2). (B) PCR-based genotyping of the protamine-Cre transgenic mouse (lane 1) and Recf mouse with loxP sites ﬂ anking MEx1 and 2 
(lane 2) that were mated to obtain double heterozygotes (lane 3). After germline recombination, offspring contain the deleted Rec allele (lane 4). PCR analy-
sis of embryos at E9.5 conﬁ rms early embryonic survival of homozygous knockouts (lanes 9, 11, and 14). (C) Pedigree for animals analyzed in B. (D) SDS-
agarose gels of wild-type (lane 1), heterozygous (lane 2), and knockout hearts (lane 3) of E9.5 animals and adult heterozygous (lane 4) and wild-type 
animals (lane 5). Titin proteins of the predicted sizes are expressed in knockout animals. Because embryonic titin is expressed as a larger isoform, differ-
ences in migration are more prevalent in T2 titin. Truncated titin (Rec) is more stable in the embryo compared with adult heterozygotes (ratio of wild-type/
knockout protein in lanes 2 and 4). Homozygous adults could not be obtained. (E) In situ hybridization of whole-mount E9.5 embryos using an antisense 
probe directed against the kinase region (a and b) and a probe that recognizes a region upstream of the kinase domain (prekin in c and d). Both heart 
and somites are stained in all controls, whereas the kinase probe in knockout animals does not produce a signal (b). Note the smaller body size of titin 
M-line knockout animals (KO). WT, wild type. Bar, 500 μm.
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 expression of the Cre recombinase under control of the prot-
amine promoter to convert our conditional knockout model into 
a constitutive titin M line–defi cient animal (Fig. 1 A).  After re-
combination, the mutant titin allele is transmitted through the 
male germline and leads to the expression of a titin protein that 
is defi cient in the titin kinase region encoded by titin’s MEx1 
and 2 (Fig. 1, B–D). In addition to the kinase domain, this 
region contains binding sites for the ubiquitin ligase MuRF-1 
(muscle-specifi c RING fi nger protein 1), signaling proteins such 
as calmodulin and FHL2 (four and a half LIM-only protein 2), 
and the M-band protein myomesin (a detailed M-band pro-
tein map indicating the deletion is provided in Fig. 7). Although 
heterozygous knockout animals are fertile and do not display 
any phenotypic abnormalities, homozygous knockouts die in 
midgestation (Fig. 1 B and Table I).  Knockout, heterozygous, 
and wild-type animals are present at the appropriate Mendelian 
ratios and express titin isoforms of the expected sizes. Unlike 
in embryonic development, the adult M line–defi cient titin is 
expressed at lower levels than the wild-type isoform (compare 
adult with embryonic heterozygous  animals; Fig. 1 D).
Expression of the wild-type and truncated titin is restricted 
to the heart and somites in the developing embryo (Fig. 1 E), as 
shown by in situ hybridization. At E9.5, there is no titin MEx1 
expression detectable in knockout hearts. Compared with the 
wild-type and heterozygous animals, head and body size are 
 reduced. The symmetrical body shape is unlike the shrunken head 
phenotype observed in the Shru mutant, which maps to the titin 
locus (May et al., 2004).
A beating heart can develop in the absence 
of titin’s kinase region
We followed the embryonic phenotype from E9, when knock-
out embryos are of similar size as their littermates and display 
proper development. This is not only refl ected in identical car-
diac morphology but also in appropriate initiation and mainte-
nance of the heartbeat in both knockout and wild-type embryos 
(Fig. 2, A and B; and Figs. S1 and S2, available at http://www.
jcb.org/cgi/content/full/jcb.200601014/DC1). Because embry-
onic development at the organ, cellular, and ultrastructural level 
did not differ between wild-type and heterozygous animals, we 
restricted all further comparisons to wild-type and homozygous 
knockout animals.
At E10, the mutant embryo appears normal (including the 
ratio of heart to body size) but small for its age. The heart un-
dergoes proper looping, but trabeculation and wall thickness are 
reduced (Fig. S2). By day 11, atrophy results in instability of the 
ventricular wall with pericardial effusion (Fig. 2 B). At this 
stage, the developmental delay is refl ected in the decreased num-
ber of somites in M-line knockout embryos (Fig. 1 E, c vs. d).
Failure to thrive is secondary to impaired 
cardiac function
The reduced cardiac wall thickness and asystole (loss of 
 cardiac activity) from E9.5, together with the failure to thrive, 
led us to investigate apoptosis in muscle and nonmuscle tis-
sues as a potential mechanism. At E9.5, when we fi rst see a 
Figure 2. Knockout embryos develop nor-
mally up to E9.0, followed by a failure to 
thrive. (A) The wild-type (WT) and knockout 
(KO) embryos at E9.0 (a and b) develop nor-
mally with appropriate cardiac size and func-
tion. The mutant embryo at E10.0 (d) appears 
normal, including normal cardiac morphology, 
but is small for its age. At E11.0, embryonic 
and cardiac development of the mutant is de-
layed with reduced body size and pericardial 
hemorrhage (f). Arrows point to the heart. 
(B) Histological analysis demonstrates normal 
development of the left ventricle and myocar-
dium until E9.0. At E10.0, proper looping 
takes place, but ventricular wall thickness and 
trabeculation are reduced compared with 
wild-type animals (f vs. e; and Fig S2, avail-
able at http://www.jcb.org/cgi/content/full/
jcb.200601014/DC1). At E11.0, the differ-
ence in wall thickness becomes more promi-
nent and is accompanied by cellular inﬁ ltration 
of the knockout pericardium (f, arrowheads). 
A, atrium; LA, left atrium; RA, right atrium; 
V, ventricle; M, myocardium; T, trabeculation. 
Bars, 500 μm.
Table I. Embryonic lethality of titin M-line knockout mice
Stage +/+ +/− −/−
% % %
E8.5 26 (12) 57 (26) 17 (8)
E9.0 25 (8) 52 (16) 23 (7)
E9.5 23 (44) 55 (106) 22 (43)
E10.0 24 (7) 55 (16) 21 (6)
E10.5 18 (19) 62 (64) 20 (21)
E11.0 13 (1) 62 (5) 25 (2)
E11.5 23 (7) 58 (18) 19 (6)
P1a 29 (21) 71 (51) 0 (0)
Stage is indicated as the embryonic day after coitum. Absolute numbers of wild-
type (+/+), heterozygous (+/−), and knockout animals (−/−) are provided 
in parentheses.
aPostnatal day 1.
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genotype-dependent size difference, the level of apoptosis is com-
parable between knockout and wild-type animals (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200601014/DC1). 
At E10.5, apoptosis is significantly increased in knockout 
 animals, particularly around the peritoneal cavity in the ab-
dominal part of the trunk (Fig. S3, bottom). Because non-
muscle knockout cells divide and differentiate normally until 
cardiac function is affected, there is no primary defect in non-
muscle cells that would interfere with the cell cycle or cause 
apoptosis. The increased apoptosis from E9.5 in knockout 
 animals affects all tissues. It is not increased in cardiac versus 
extracardiac tissue (abdominal cavity, limbs, and brain), which 
Figure 3. Ultrastructural analysis of cardiac 
sarcomere maturation. (A) Sarcomeres assem-
ble in both wild-type (WT) and knockout ani-
mals (KO), but lateral growth is impaired from 
day 10 in knockout animals followed by sarco-
mere disassembly (h and j). At E11, nearly all 
sarcomeric structures are dissolved. (B) Myoﬁ -
bril diameter was quantiﬁ ed for >50 ﬁ bers in 
duplicate with two animals per group. The lat-
eral growth of knockout myoﬁ brils lags behind 
the increase in wild-type myoﬁ bril diameter. 
The loss of sarcomere structure precludes the 
analysis of E10.5 and 11.0 sarcomeres in 
knockout animals. **, P < 0.01. (C) Sarco-
mere length was not changed in wild-type ver-
sus knockout animals before disassembly at 
E10.5. Error bars represent SD. (D) M-band 
and Z-disc structures at E10.0 do not differ sig-
niﬁ cantly between knockouts and wild-type 
 animals, and there is no change in the A/I 
alignment. Slight variation in M-band align-
ment is present in both knockout and wild-type 
animals (arrowheads in a and b). Embryonic 
sarcomeres do not display an electron-dense 
M band. L, lipid; Mi, mitochondrium; N, nu-
cleus; Z, Z disc; M, M band. Bars, 0.5 μm.
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would also indicate a secondary change and does not imply a 
nonmuscle function of titin’s M-line region such as an anti-
apoptotic effect.
Titin’s kinase region is dispensable for 
initial sarcomere assembly but is required 
for lateral growth and stabilization 
of the sarcomere
Titin’s kinase domain has been proposed to be required for sar-
comere assembly. As a mechanism, it has been suggested that 
phosphorylation of the titin kinase substrate T-cap, which tran-
siently localizes to the M band during development, coordinates 
the assembly of Z-line and M-band lattices during myofi brillo-
genesis (Mayans et al., 1998). To investigate titin’s structural 
functions, we have used electron microscopy to follow sarco-
mere assembly, growth, and disassembly. At E9, assembled sar-
comeres were detected in the knockout, and no structural 
alteration compared with wild-type sarcomeres was apparent 
(Fig. 3 A). SDS-PAGE revealed the exclusive expression of 
 kinase-defi cient titin in our knockout animals (Fig. 1 D, lane 3). 
Therefore, our ultrastructural data suggest that the titin kinase 
domain is not required for sarcomere assembly. From E9.5, 
knockout myofi brils fail to grow laterally (quantifi cation in Fig. 
3 B), but Z-disc and M-band structure are maintained through 
E10. Thereafter, knockout sarcomeres disassemble, and, at E11, 
only a few fi laments in disarray remain.
Figure 4. Integration of titin into the sarco-
mere. Coimmunostaining with antibodies di-
rected against α-actinin and titin’s N2B region 
(A), the A/I region (B), and the M-line region 
(C) reveals that titin is expressed and incorpo-
rated into the I band of the sarcomere in both 
wild-type (WT) and knockout (KO) animals (A). 
The N2B region is located proximal to the Z 
disc, and, thus, N2B staining partially over-
laps with α-actinin staining at E9.5 (yellow). In 
knockouts at day 10.5, sarcomeres disassem-
ble with few areas of striation remaining (open 
arrowheads). In areas of disassembly where 
α-actinin localizes in spotted aggregates 
(closed arrowheads), the N2B region is distrib-
uted diffusely. (B) The T3 antibody stains titin at 
the beginning of the A band. Correct localiza-
tion in wild-type and knockouts (doublets 
marked with arrowheads) indicates that titin 
transitions properly into the A band. (C) Unlike 
the N2B region and the T3 epitope, titin’s M 
line (M8/M9) is not integrated into the sarco-
mere in the absence of the kinase region. 
 Although wild-type sarcomeres at different 
stages of embryonic development and in the 
adult animal show the expected striated pat-
tern with alternating Z-disc and M-band epit-
opes, knockout animals fail to incorporate titin 
into the M band. Already at E9.5, titin’s COOH 
terminus localizes diffusely. (D) To conﬁ rm the 
presence of titin’s M8/M9 epitope in the ki-
nase region–deﬁ cient protein, we used West-
ern blot analysis of the wild-type and truncated 
titin in heterozygous embryos. Bars, 5 μm.
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Thus, the titin M-line region has multiple effects on the 
molecular development of the sarcomere: it is involved in regu-
lating lateral growth and fortifi cation of the sarcomere. The un-
derlying mechanism could involve a role in signal transduction 
or as a scaffold for structural proteins.
Proper localization of Z-disc and M-band 
proteins proceeds even without M-line–
deﬁ cient titin forming a continuous ﬁ lament
The embryonic heart does not reveal M bands as an electron-
dense area (Smolich, 1995), so electron microscopy is blind to 
early changes in the developing cardiac M band. Thus, although 
titin M line–defi cient and wild-type sarcomeres are indistin-
guishable at the ultrastructural level early in development, their 
structure and molecular composition could already be affected.
Accordingly, we followed the integration of titin into the 
sarcomere using antibodies directed against titin’s I-band region 
proximal to the Z disc (N2B) and its COOH terminus (M8/M9) 
as well as an anti–α-actinin antibody as a marker for the Z disc 
(Fig. 4; also see the localization of titin epitopes in Fig. S2).
In wild-type animals, titin molecules overlap at the Z disc 
and M band to form a continuous fi lament system (Fig. 4, com-
pare A with B; Obermann et al., 1996; Gregorio et al., 1998; 
Young et al., 1998). In knockout animals, titin’s NH2 terminus 
is incorporated into the Z disc, which results in close proximity 
of α-actinin and the titin N2B region at E9.5. Upon  disassembly, 
Z bodies distribute from regular striation (Fig. 4 A, open arrow-
heads) to random patches of variable size (Fig. 4 A, closed 
 arrowheads). This sign of disintegration of the Z bodies is com-
plemented by the diffuse staining for titin’s N2B region, which 
is now separate from α-actinin.
Unlike the NH2 terminus of kinase-defi cient titin, its 
M-line region is not integrated into the developing sarcomere at all 
(Fig. 4 B). Even at E9.5, there is no accumulation of titin’s M8/
M9 epitope between Z discs. The absence of a distinct M8/M9 
staining could result either from the mislocalization of M8/M9 
or from the expression of a truncated protein, which does not 
only lack the kinase region but fails to include the M8/M9 
 domains. We used Western blot analysis of embryonic hearts 
 derived from wild-type and heterozygous animals to confi rm 
proper expression of the truncated M-line region (Fig. 4 C). 
 Because the M8/M9 epitope is included in the wild-type and 
knockout protein of heterozygous animals, the loss of M-line 
staining is indeed the result of the partial integration of kinase 
region–defi cient titin into the sarcomere at the Z disc only.
Next, we used immunofl uorescence staining to follow 
M-band assembly and the fate of myomesin in the absence of titin’s 
myomesin-binding site (see Fig. 7). The periodic myomesin 
staining indicates that even in the absence of titin’s M line, 
myomesin is incorporated into the sarcomere (Fig. 5 A). It lo-
calizes properly between Z discs, as demonstrated by costaining 
with the Z-disc protein α-actinin. Nevertheless, in knockout an-
imals, myomesin staining is more diffuse. This might refl ect the 
reduced number of binding sites in the absence of titin’s kinase 
region because myomesin levels are not up-regulated in knock-
out versus wild-type animals (Fig. 5 B).
Differential expression of titin-binding 
proteins is linked to diverse functions 
of M-line titin in the adult 
and embryonic sarcomere
In both our conditional titin knockout animals (Gotthardt et al., 
2003; Peng et al., 2006) and the conventional knockout de-
scribed in this study, titin kinase-defi cient sarcomeres disas-
semble. Nevertheless, structure is preserved better in the adult 
than in the developing sarcomere with titin’s M line integrated 
properly, even in the absence of titin’s kinase region. Titin’s sar-
comeric functions are in part inherent in the protein (spacer/
spring) and in part relayed through protein–protein interactions. 
Thus, we used expression analysis of both titin and its binding 
proteins at various stages of development to help discriminate 
their roles in the embryonic and adult heart. Overall mRNA lev-
els of titin and its binding proteins are reduced in embryonic de-
velopment and increase by up to two orders of magnitude from 
E9.5 to adulthood.
To monitor titin expression, we used TaqMan probes that 
distinguish the Z disc, kinase region, M line, and an internal re-
gion of titin (Fig. 6 A). Adult titin isoforms lack various internal 
exons of the Ig and PEVK regions (Lahmers et al., 2004; Opitz 
et al., 2004). The novex-3 isoform, which encodes a truncated 
Figure 5. M-band assembly in the absence of 
titin’s M-line region. (A) Although titin is not incor-
porated into the M band, myomesin (Myom1 EH) 
localizes between Z discs (α-actinin staining). 
(B) The more diffuse myomesin staining in titin 
kinase region knockout (KO) animals is not re-
lated to the overexpression of myomesin, as 
demonstrated by Western blotting at both E9.5 
and 10.5. Expression was normalized to actin. 
WT, wild type. Bar, 5 μm.
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700-kD protein, does not even include the M-line region (Bang 
et al., 2001).
Correlating titin’s Z-disc and M-line expression allows 
us to determine the amount of full-length versus novex-3 titin. 
Increased embryonic M-line RNA levels indicate a higher ratio 
of full-length titin compared with the truncated novex-3 isoform 
in the developing embryo from E9.5 (Fig. 6 A). In early develop-
ment, we see a reduced expression of the heart-specifi c titin 
N2B region, which would imply altered elastic properties of the 
titin fi lament system.
Various titin-binding proteins have been proposed to act 
as a substrate for the titin kinase and regulate embryonic sarco-
mere assembly. Of these, T-cap, Sqstm1 (sequestosome 1), and 
Nbr1 (neighbor of BRCA1 gene 1) are expressed at <20% of 
adult levels in the embryonic heart (Fig. 6 B). Combining pro-
tein and RNA data, MuRF-1, myomesin, and calmodulin are 
the only proteins expressed in signifi cant amounts at the time 
when the knockout phenotype develops (Fig. 6, B and C; and 
Fig. S2). This would argue against a role of the proposed ki-
nase substrates T-cap, Sqstm1, and Nbr1 in the development of 
the phenotype.
Sarcomere disassembly in embryonic 
knockout hearts is not compensated 
for by increased expression 
of sarcomeric proteins or 
hypertrophic signal transduction
Although the sarcomeric phenotype can be explained by struc-
tural features of M-line titin alone, additional changes in signal 
transduction or secondary effects could precipitate or modify 
the phenotype. Therefore, we compared the expression of pro-
teins involved in sarcomere assembly and hypertrophic signal 
transduction in wild-type and knockout embryos. Unexpect-
edly, neither titin nor its binding proteins are up-regulated in 
 response to the elimination of titin’s kinase region (Fig. S2). 
Furthermore, the hypertrophic gene response accompanying the 
adult kinase region knockout phenotype (unpublished data) is 
not elicited in the embryonic heart.
We conclude that the initial sarcomere assembly and matu-
ration can proceed normally, even in the absence of titin’s kinase 
region, up until titin is incorporated into the M band. The lack of 
both changes in signal transduction and the compensatory up-
regulation of titin and its binding proteins implies that titin’s 
M-line region, including the kinase domain, covers structural 
more than signaling functions in the developing sarcomere.
Discussion
Because of its size, it has been notoriously diffi cult to study  titin’s 
signaling and structural functions in vivo. Although  multiple  titin-
defi cient animals and cell lines have been generated (Person et al., 
2000; Garvey et al., 2002; Xu et al., 2002;  Gotthardt et al., 2003; 
Figure 6. Sarcomere metabolism in embryonic development versus 
adulthood. Real-time RT-PCR analysis of titin (A) and its M line–binding 
proteins (B) demonstrates that transcript levels change by up to two or-
ders of magnitude from early cardiac development to adulthood. (A) The 
cardiac-speciﬁ c N2B region is barely expressed in the embryonic heart. 
Differences in Z-disc and M-line levels indicate differences in the ratio of 
full-length titin to the NH2-terminal novex isoforms, with more full-length 
titin expressed in the developing embryo, as depicted in Fig. S2 A (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200601014/DC1). 
(B) Except for calmodulin, MuRF-2, and Nbr1, transcript levels of most 
binding proteins are <20% of adult levels at E9.5. The proposed kinase 
substrate T-cap shows the lowest embryonic expression of all transcripts 
tested. (C) Most M-line titin–binding proteins can be detected by West-
ern blotting only after E9.5, when cardiac pathology in knockout ani-
mals is already present. Notable exceptions are MuRF-1, which is 
expressed at similar levels throughout embryonic development, calmod-
ulin, and myomesin. Error bars represent SD. Calm, calmodulin; FHL2, 
four and a half LIM-only protein 2; Nbr1, neighbor of BRCA1 gene 1; 
Sqstm1, sequestosome 1; MuRF, muscle-speciﬁ c RING ﬁ nger protein; 
T-cap, titin cap.
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Miller et al., 2003; Peng et al., 2006), it has not been possible so 
far to address titin’s role in early sarcomere assembly.
In this study, we present a novel animal model to investigate 
titin in the developing sarcomere. We have generated an internal 
homozygous deletion in the titin gene, which excises  titin’s kinase 
region (MEx1 and 2), allowing us to study its role in sarcomere 
assembly and address its potential functions in nonmuscle cells.
Nonmuscle functions of M-line titin
Titin was originally discovered in striated muscle, but nonmus-
cle titins have been described in various tissues such as the duo-
denal epithelium and smooth muscle (Eilertsen and Keller, 
1992; Eilertsen et al., 1994; Keller et al., 2000). Titin’s role in 
nonmuscle cells is poorly understood, but it has been implicated 
in cytokinesis through localization to the cleavage furrows 
(Keller et al., 2000) and in chromosome condensation and mito-
sis through localization to mitotic chromosomes and the spindle 
machinery (Machado et al., 1998; Wernyj et al., 2001). So far, 
functional data are only available for the Drosophila homologue 
D-titin. Drosophila defi cient in D-titin show chromosome un-
dercondensation, premature sister chromatid separation, and 
aneuploidy (Machado and Andrew, 2000). Our titin-defi cient 
animals as well as the published zebrafi sh and mouse titin mu-
tants do not display any nonmuscle phenotypes apart from de-
fects that are secondary to impaired cardiac and skeletal muscle 
function (Garvey et al., 2002; Xu et al., 2002; May et al., 2004). 
The differences between Drosophila and mouse/zebrafi sh might 
be attributed to the different titin domains involved; in particu-
lar, the titin kinase region is not present in D-titin.
Because our titin M line–defi cient animals develop normally 
until midgestation, we can exclude an essential cellular function 
of the kinase region in cell division and fi lament assembly. 
Knockout muscle and nonmuscle cells undergo apoptosis only 
after E9.5, which can be attributed to impaired cardiac function. 
The severity of the cardiac phenotype precludes the analysis of 
smooth muscle and intestinal functions, which would have to be 
addressed in the respective tissue-specifi c knockout animals.
The titin kinase in sarcomere assembly
Various models of sarcomerogenesis have been proposed using 
data derived from cultured chick cardiomyocytes (Schultheiss 
et al., 1990; Rhee et al., 1994). Although they differ with respect 
to early thin and thick fi lament assembly, they ultimately agree 
on the joint assembly of actin and myosin fi laments along a 
common fi lament plane late in sarcomere development and 
on the necessity of adaptor proteins to cross-link Z bodies and 
M-band proteins into periodic A and I bands (Dabiri et al., 1997; 
van der Ven et al., 1999; Rudy et al., 2001).
Titin has been proposed to act as a template for sarcomere 
assembly through its unique domain structure with multiple 
protein interaction domains and its ability to multimerize into 
fi laments extending throughout the muscle fi ber (Labeit and 
Kolmerer, 1995; Trinick, 1996; van der Loop et al., 1996; 
Obermann et al., 1997; Gregorio et al., 1998). The titin kinase 
domain in particular and its substrate T-cap have been impli-
cated in the early stages of sarcomere assembly based on struc-
tural and in vitro data (Mayans et al., 1998).
The compartmentalization of titin’s mechanical, struc-
tural, and signaling functions facilitates the analysis of indi-
vidual subdomains. Nevertheless, a truncated, overexpressed 
protein fragment does not necessarily refl ect the activity of 
a domain integrated into the native protein in the context of 
the sarcomere. This does not only apply to titin’s elastic do-
mains but also to titin’s kinase region. To circumvent this 
problem, we used site-specifi c recombination to excise titin’s 
kinase region and compared sarcomere assembly in our titin 
M line– defi cient and wild-type embryos. This approach com-
bines the advantage of eliminating tissue culture artifacts and 
providing a clean genetic model to address the role of titin’s ki-
nase domain in sarcomere assembly. For the fi rst time, we show 
that phosphorylating T-cap by the titin kinase is not important 
for initial sarcomere assembly. Not only do sarcomeres form 
in the absence of titin’s kinase domain, but, furthermore, the 
T-cap protein is not detectable in early sarcomere development 
(E9.5) by Western blotting (Fig. 6) or by immunoprecipitation 
(not depicted). Although T-cap overexpression in tissue culture 
interferes with sarcomere assembly, the physiological role is 
debatable because the earliest published detection in mice is 
E10.5 (transcript level only) when fully assembled sarcomeres 
already exist (Gregorio et al., 1998).
Patients defi cient in T-cap develop limb girdle muscular 
dystrophy type 2G (Moreira et al., 2000). Because even homo-
zygous patients do not show symptoms before 2 yr of age, 
 sarcomeres can assemble even in the absence of T-cap. The 
truncated T-cap protein expressed in these patients (premature 
stop codon in exon 2) is not detected in the sarcomere; neverthe-
less, ultrastructure is maintained (Vainzof et al., 2002).
Integration of titin into the developing 
sarcomere
Sarcomere assembly differs between skeletal muscle and 
 cardiomyocytes. In skeletal muscle, titin’s Z-disc and M-band 
regions integrate into the sarcomere almost at the same stage of 
differentiation, before internal A- and I-band epitopes are local-
ized (Fürst et al., 1989; Kontrogianni-Konstantopoulos et al., 
2006), whereas in cardiomyocytes, the integration of titin into 
the M band is delayed (Ehler et al., 1999). In our titin kinase 
knockout mice, titin is not integrated into the embryonic 
M band and, thus, fails to form a continuous elastic titin  fi lament. 
Nevertheless, cardiac sarcomeres in titin M line–defi cient 
 animals assemble and start to contract. Moreover, the M-band 
protein myomesin targets between Z discs even in the absence 
of its binding site in M-line titin, although the localization is 
more diffuse.
The ruler hypothesis states that the titin fi lament covers an 
essential role as a blueprint in sarcomerogenesis (Labeit and 
Kolmerer, 1995; Trinick, 1996; van der Loop et al., 1996; 
 Obermann et al., 1997; Gregorio et al., 1998). Our data show 
that sarcomere length is not affected after the removal of 
M-line titin, which might indicate that at least some of titin’s 
 scaffold function can be taken over by other proteins in the 
myofi lament. This is facilitated by most sarcomeric proteins 
 interacting with multiple partners, such as myomesin, which 
not only dimerizes (Lange et al., 2005a) but also binds to both 
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 myosin and titin (Auerbach et al., 1999). The proper localiza-
tion of the T3 epitope at the A→I transition would argue for the 
proper transition of titin into the A band, where it is cross-linked 
with the thick fi lament. Sarcomere spacing would thus be main-
tained through the titin–myosin fi lament.
Structural, mechanical, and signaling 
functions of titin in the embryonic 
sarcomere
Titin has been proposed to keep thick fi laments centered in re-
laxed as well as in activated myofi brils, generating restoring 
forces to counteract the unequal contraction of neighboring sar-
comeres and to keep multiple sarcomeres in register (Horowits 
and Podolsky, 1987; Horowits et al., 1989). In fact, dislocation 
of the A band has been demonstrated in continuously activated 
muscle (Page and Huxley, 1963), but in our contracting knock-
out hearts, neither the mislocalization of A bands nor the mis-
alignment of the M band could be detected.
Nevertheless, sarcomere disassembly in our titin-defi cient 
animals clearly demonstrates that a discontinuous titin fi lament 
is incompatible with the maintenance of sarcomere structure un-
der mechanical load. This could be a primary defect of titin or 
be caused by the altered composition of titin-defi cient M bands 
with the mislocalization of myomesin (Agarkova et al., 2003; 
Agarkova and Perriard, 2005). It is tempting to speculate that 
 titin’s integration into the M band allows it to monitor shearing 
forces between neighboring thick fi laments (Agarkova and 
 Perriard, 2005). How this might be affected in our M line–
 defi cient animals will be the focus of future mechanical studies.
The integration of titin into the M band allows it to stabi-
lize the sarcomere (Horowits and Podolsky, 1987). This alone 
would explain the sarcomeric phenotype in our M-line titin–
 defi cient animals in the absence of changes in signal transduction. 
We were not able to confi rm an additional signaling function for 
the titin kinase domain, which has been proposed to act as 
a stretch sensor based on in silico data (Grater et al., 2005). 
 Indeed, patients suffering from hereditary myopathy with early 
respiratory failure carry a mutant regulatory kinase domain that 
is supposedly involved in mechanosignaling, which only causes 
pathology in the adult (Lange et al., 2005b). In our adult titin 
kinase knockout mice, changes in signal transduction involve 
increased MAPK signal transduction (unpublished data). This 
is part of the hypertrophic signaling response secondary to the 
cardiomyopathy phenotype and could not be detected in the ki-
nase region–defi cient embryonic heart using hypertrophy mark-
ers, including genes in the MAPK pathway.
The MAPK pathway has been implicated in regulating the 
serial versus parallel assembly of sarcomeres (Nicol et al., 
2001). Because we do not see changes in MAPK signaling in 
the titin knockout, the mechanism underlying impaired growth 
of the myofi bril is independent of leukemia inhibitory factor/
MAPK signal transduction. Lateral growth with the assembly 
of α-actinin into broad Z lines is a sign of proper maturation of 
the nascent to mature myofi bril (Dabiri et al., 1997). The imma-
ture dots we observe in immunostaining thus indicate a problem 
of sarcomere maturation, not of signal transduction.
Adult versus embryonic sarcomere 
dynamics and structure
Differentiated embryonic cardiomyocytes can undergo mitosis, 
which requires the disassembly of preexisting sarcomeres 
(Ahuja et al., 2004). Based on this fi nding, the inability of adult 
Figure 7. Signaling and structural functions of titin’s M-line region. The titin M-line region (gray) mainly consists of Ig domains labeled M1–M10, a ﬁ bro-
nectin (FN3), and a kinase domain (CD + RD). The 214-kD region deleted in our titin M line–deﬁ cient animals (bracket) contains binding sites for MuRF-1, 
Nbr1, calmodulin, FHL2 (signaling proteins in yellow), and myomesin (green). Myomesin integrates into the M band through interaction with myosin (My1), 
titin (My4), and dimerization (My13). In vitro substrates for the truncated soluble kinase are T-cap, p62, and Nbr1 (blue). The titin M-line region has been 
proposed to cover structural (sarcomere assembly) as well as signaling functions (hypertrophy/atrophy) through its multiple binding partners. Proteins ex-
pressed at low levels or below the detection limit of our Western blot in the embryonic heart are semitransparent. Protein–protein interactions are indicated 
by double-pointed arrows. The protein domains depicted are PB1 (Phox and Bem1p domain), Z (zinc-binding domain), U (ubiquitin-associated domain), 
IG (Ig-like domain), FN3 (ﬁ bronectin type 3 domain), CD (titin kinase catalytic domain), RD (titin kinase regulatory domain), R (RING ﬁ nger), B (B box–type 
zinc ﬁ nger), E (EF hand calcium-binding motif), and L (LIM domain).
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cardiomyocytes to divide has been attributed to differences in 
sarcomere structure and dynamics in the embryonic versus adult 
animal. These differences could also be the basis of phenotypic 
differences in our adult and embryonic kinase region–defi cient 
animals. In kinase-defi cient adult hearts, we have demonstrated 
by immunoelectron microscopy that in the absence of titin’s ki-
nase region (loss of MuRF-1 localization), titin is still integrated 
into the sarcomere (Gotthardt et al., 2003). This includes titin’s 
M8/M9 epitope, which remains at the widening M band despite 
progressive deletion of the kinase region. In the embryonic sar-
comere, mutant titin is not localized at the M band despite 
proper integration into the Z disc and expression of the M8/M9 
epitope. This difference might be attributable to changes in titin 
isoform or titin-binding protein expression during cardiac 
 development. Increased expression of titin’s novex isoform, 
T-cap, as well as all titin M line–binding proteins in the adult 
could  account for increased stability of the sarcomere. Conver-
sely, the lack of titin-binding protein expression in the  embryonic 
M line–defi cient animals makes it unlikely that titin signaling 
through T-cap or FHL2 is the basis for impaired lateral growth 
and disassembly of the embryonic sarcomere (compare translu-
cent proteins in Fig. 7).
Apart from titin, extrasarcomeric fi lament systems can 
promote sarcomere stability. This includes the spectrin, ankyrin, 
obscurin, and possibly the intermediate fi lament system (Flick 
and Konieczny, 2000; Bagnato et al., 2003; Kontrogianni-
 Konstantopoulos et al., 2004, 2006). These structural proteins 
could provide the basis for early sarcomerogenesis and make 
the titin fi lament system dispensable in the initial assembly of 
the sarcomere and localization of M-band proteins. The subse-
quent disassembly is modulated by sarcomere stability, which 
depends on the proteome of embryonic versus adult cardiomyo-
cytes and on the connection between the sarcomere and addi-
tional fi lament systems.
Differences in the expression and assembly of cardiac 
proteins determine both structure and function of the adult and 
embryonic sarcomere. The ability to regenerate sarcomeres and 
allow for mitosis in the embryo comes at the expense of im-
paired stability and contractile function.
Understanding how titin and its binding proteins shape 
and regulate sarcomere assembly and dynamics could help de-
velop novel therapeutic strategies to improve sarcomere stabil-
ity in patients with muscle disease.
Materials and methods
Generation of titin M-line knockout mice
The transgenic mice with loxP sites ﬂ anking titin MEx1 and 2 have been 
described previously (Gotthardt et al., 2003). They were converted from a 
conditional to a complete knockout using protamine-Cre transgenic mice 
(The Jackson Laboratory; O’Gorman et al., 1997). Male double heterozy-
gotes (protamine-Cre/wild type; titin MEx1/2lox/wt) were backcrossed to 
129/SvEms-+Ter?/J to obtain a clean colony of heterozygous knockouts 
devoid of the Cre transgene (TiMEx1/2rec/wt).
Genotyping
Template DNA was prepared from yolk sac or tail according to standard pro-
cedures, and recombination of the titin locus was monitored by PCR (primers 
PL1 and PL4). Lox and wild-type loci were typed using primers PL1 and PL2. 
All primers used have been described previously (Gotthardt et al., 2003).
Animal procedures (breeding and maintenance)
Timed matings were set up between heterozygotes (MEx1/2rec/wt). The 
morning of vaginal plug detection was regarded as day 0.5 after concep-
tion. Embryos were harvested at E8.5, 9.0, 9.5, 10.0, 10.5, 11.0, and 
11.5. All experiments involving animals were performed according to in-
stitutional and National Institutes of Health (NIH) Using Animals in Intramural 
Research guidelines.
Gel electrophoresis and Western blot analysis
SDS lysates for titin gels were prepared by homogenization of pooled dis-
sected hearts from at least three different litters in 0.5 M Tris-HCl, pH 6.8, 
followed by DNase digestion for 30 min at 37°C and lysis in a buffer con-
taining 8 M urea, 2 M thiourea, 3% SDS, 75 mM DTT, 0.05 M Tris-HCl, 
pH 8.6, and 0.03% bromphenolblue. Titin isoforms were separated using 
an SDS-agarose gel electrophoresis system followed by staining with 
 Coomassie (Warren et al., 2003) or Sypro Ruby (Invitrogen).
For Western blot analysis, heart extracts were prepared as de-
scribed above except using lysis buffer containing 6 M urea, 2% Chaps, 
1 mM DTT, 1 mM PMSF, and 1 μg/ml leupeptin. Samples were equally 
loaded on an 8 or 12% SDS-PAGE gel or SDS-agarose gels for titin and 
transferred onto nitrocellulose membranes (GE Healthcare). Membranes 
were blocked with 5% skim milk in PBS–Tween 20 followed by incubation 
with the following antibodies: 1:500 afﬁ nity-puriﬁ ed polyclonal anti–T-cap 
antibody (for the generation of antibody; see below), 1:750 mono-
clonal anti-FHL2 (MBL International Corporation), 1:10,000 polyclonal 
antimyomesin EH (gift from J.-C. Perriard, Eidgenössische Technische 
Hochschule [ETH] Zürich, Zurich, Switzerland), 1:200 monoclonal anti–
MuRF-2 (gift from S. Labeit, Universitätsklinikum Mannheim, Mannheim, 
Germany), 1:500 afﬁ nity-puriﬁ ed polyclonal anti–MuRF-1 (gift from 
D. Glass, Regeneron Pharmaceuticals, Inc., Tarrytown, NY), and 1:2,000 
polyclonal anti-actin (Sigma-Aldrich). All antibodies were diluted in 5% 
skim milk in PBS and incubated for 2 h at RT or at 4°C overnight. HRP-
 conjugated goat anti–rabbit IgG (Sigma-Aldrich) and goat anti–mouse 
IgG (Calbiochem) were used as the secondary antibodies. The blots were 
washed in PBS–Tween 20 and developed by chemiluminescence staining 
using ECL (Supersignal West Pico Chemiluminescent Substrate; Pierce 
Chemical Co.).
Morphological and histological analysis
Embryos were dissected in RNase-free PBS and ﬁ xed overnight in freshly 
prepared 4% PFA in PBS, pH 7.4, at 4°C. The developmental stage of 
 embryos was determined by the days after coitum and the number 
of somites.
For parafﬁ n embedding, embryos were hydrated followed by dehy-
dration through graded ethanol solutions. Transverse sections were cut at 
5 μm, deparafﬁ nized, and stained with 0.5% hematoxylin and 0.1% 
 eosin. Multiple serial sections were stained and analyzed for each devel-
opmental stage and genotype.
In situ hybridization
Whole-mount RNA in situ hybridization for the exon preceding MEx1 and 
for MEx1 was performed using digoxigenin-labeled antisense riboprobes. 
RNA labeling of linearized plasmid templates was accomplished with di-
goxigenin-UTP by in vitro transcription with T7 polymerase according to 
the manufacturer’s speciﬁ cations (Roche Diagnostics). After ﬁ xation, em-
bryos were washed in PBS plus 0.15% Tween 20, dehydrated, bleached 
with 25% H2O2 in MeOH, and rehydrated in an ascending/descending 
series of methanol (25, 50, and 75% in PBS–Tween 20 and 100% methanol). 
The tissue was permeabilized with 20 μg/ml proteinase K and reﬁ xed with 
4% PFA and 0.2% glutaraldehyde for 20 min at room temperature. 
 Embryos were prehybridized in 50% formamide, 5× SSC (0.75 M NaCl 
and 0.75 M sodium citrate, pH 7.0), 0.1 mg/ml single-stranded DNA 
(Sigma-Aldrich), 40 μg/ml heparin, 50 μg/ml tRNA, 0.15% Tween 20, 
and 60 mM citric acid. Hybridization of the digoxigenin-labeled probe 
was performed overnight at 65°C. Embryos were washed in solution 1 
(50% formamide, 5× SSC, and 0.15% Tween 20) at 65°C twice for 
40 min, washed in solution 2 (10 mM Tris, pH 7.5, 50 mM NaCl, and 
0.15% Tween 20) three times for 15 min, and washed in solution 3 (50% 
formamide, 2× SSC, and 0.15% Tween 20) three times for 60 min. 
 Embryos were incubated with 0.75 U antidigoxigenin antibody, Fab frag-
ments (Roche Diagnostics) in 5% goat serum in TBS–Tween 20 overnight at 
4°C, and washed with TBS–Tween 20 for at least 8 h at room temperature. 
Embryos were stained with NBT/BCIP solution (350 and 175 μg/ml, 
 respectively; Roche Diagnostics). Images were taken after reﬁ xation with 
4% PFA and clearance with 80% glycerol.
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Immunoﬂ uorescence staining
Embryos were dissected followed by overnight ﬁ xation in 4% PFA, equili-
bration with 30% sucrose in PBS, and embedding in Tissue Tek (optimal 
cutting temperature compound; Vogel). 5-μm sagittal sections were air 
dried, ﬁ xed with 4% PFA, blocked, and permeabilized in 0.3% Triton 
X-100, 0.2% BSA, and 10% normal goat serum for 60 min. Cryosections 
were incubated overnight with primary antibodies at 4°C followed by ﬂ uo-
rescent-conjugated secondary antibodies (AlexaFluor488 goat anti–rabbit 
[Invitrogen] and Cy3 goat anti–mouse [Jackson ImmunoResearch Laborato-
ries]). Primary antibodies were used at the following dilutions: 1:500 
monoclonal antisarcomeric α-actinin (Sigma-Aldrich), 1:100 monoclonal 
anti-titin T3 (gift from D.O. Fürst, Universität Bonn, Bonn, Germany; Fürst 
et al., 1988), 1:10,000 polyclonal antimyomesin EH (gift from E. Ehler 
and J.-C. Perriard, ETH Zürich; Auerbach et al., 1997), and rabbit poly-
clonal antibodies 1:1,000 anti–titin-Z1/Z2, 1:200 titin-N2B, and 1:500 
anti–titin-M8/M9 (both were gifts from S. Labeit, Universitätsklinikum 
Mannheim; Trombitas et al., 2000). Stained tissue was mounted with ﬂ uo-
rescent mounting medium (DakoCytomation) and analyzed at room tem-
perature using Immersol 518N (Carl Zeiss MicroImaging, Inc.) on a 
confocal scanning laser microscope (LSM5 Pascal with software version 
3.0 SP2; Carl Zeiss MicroImaging, Inc.) with a plan-Neoﬂ uar 100× 1.3 
NA lens (Carl Zeiss MicroImaging, Inc.). Images were assembled using 
Photoshop 9.0 and Corel Draw 12.0.
Apoptosis assay
For TUNEL assay (terminal deoxynucleotidyltransferase-mediated dUTP-
 biotin nick end labeling), cryosections of mouse embryos were processed 
using the in situ cell death detection kit (Roche Diagnostics) according to 
the protocol supplied by the manufacturer. In brief, sections were ﬁ xed in 
4% PFA and permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate 
for 2 min on ice. After washing, slides were incubated with TdT terminal 
transferase and ﬂ uorescein-dUTP for nick end labeling. Sections were coun-
terstained with 1:500 antisarcomeric α-actinin (Sigma-Aldrich). Stained 
 tissue was analyzed using a microscope (BX51; Olympus), a CCD camera 
(Visitron Systems 7.4 Slider; Diagnostic Instruments), and MetaMorph soft-
ware version 6.2r2 (Universal Imaging Corp.).
Electron microscopy
Embryos for ultrastructural analysis of the sarcomere assembly were dis-
sected and ﬁ xed with 3% formaldehyde in 0.2 M Hepes, pH 7.4, for 
30 min followed by immersion in 8% formaldehyde/0.1% glutaraldehyde 
in 0.2 M Hepes, pH 7.4, overnight. Embryos were postﬁ xed with 1% 
OsO4 for 2 h, dehydrated in a graded ethanol series and propylene 
 oxide, and embedded in Poly/Bed 812 (Polysciences, Inc.). Ultrathin sec-
tions (70 nm) were contrasted with uranyl acetate and lead citrate and 
were examined with an electron microscope (model 910; Carl Zeiss 
 MicroImaging, Inc.). Digital images were taken with a 1k × 1k high speed 
slow scan CCD camera (Proscan). The diameter of 
25 sarcomeres per 
embryo was measured on a range of ultrathin sections taken from two em-
bryos per genotype and day of gestation using the analySIS 3.2 software 
(Soft Imaging System).
Real-time PCR
For isolation of total RNA, the hearts of 5–10 embryos from at least three lit-
ters were pooled (depending on the size and age of the embryo). RNA was 
isolated by using the RNeasy Mini Kit (QIAGEN) followed by the digestion 
of contaminating genomic DNA (RNase-Free DNase Set; QIAGEN). RNA 
concentration and purity were determined by spectrophotometry. 1 μg of 
total RNA was used for cDNA synthesis (Thermoscript First-Strand Synthesis 
System; Invitrogen). Quantitative real-time RT-PCR was performed using the 
TaqMan probe-based chemistry (Applied Biosystems). Primers and probes 
were designed using the Primer Express 1.5 software (Applied Biosystems) 
and were ordered from BioTez GmbH for the following titin amplicons: Z1/2 
forward, C G A T G G C C G C G C T A G A ; reverse, C T C A G G G A G T A T C G T C C A C-
T G T T ; probe, 6-FAM-T G A T G A T C C C C G C C G T G A C T A A A G C -TAMRA; N2B 
forward, A C A G T G G G A A A G C A A A G A C A T C ; reverse, A G G T G G C C C A G-
A G C T A C T T C ; probe, 6-FAM-G A A A G A G C T G C C C C T G T G A T C A -TAMRA; 
kinase forward, C C G A T G G A C T C A A G T A C A G G A T T ; reverse, C C C A T G C C-
T T C G A G A G T C T T ; probe, 6-FAM-T C C T T G G A A G T G G A A G T T C C A G C T A A-
G A T A C A C -TAMRA; M-line forward, G C C T T G T G T G G T A G T T C T A A A T T C A A ; 
reverse, T T T G C T G T G G C T C A T T G C T T ; probe, 6-FAM-T T T C A C C G G G A A C T-
G G G C A A -TAMRA; MuRF-1 forward (titin-binding proteins), C C G A G T G-
C A G A C G A T C A T C T C ; reverse, C C T T C A C C T G G T G G C T A T T C T C ; probe, 
6-FAM-A G C T G G A G G A C T C G T G C A G A G T G A C C -TAMRA; MuRF-2 for-
ward, T G G A G A A C G T A T C C A A G T T G G T ; reverse, C C T T T G A T G C T T C C A-
C G A T C T ; probe, 6-FAM-C A T G G A T G A G C C C G A A A T G G C A -TAMRA; ANP 
forward (hypertrophy markers), T T C T A G G C G C A G C C C C T ; reverse, G C A G -
A G C C C T C A G T T T G C T T ; probe, 6-FAM-A C C C C T C C G A T A G A T C T G C C C-
T C T T G A A -TAMRA; MAPKAP2 forward, G T G T G G G T A T C C C C C C T T C T ; reverse, 
T A C G A G T C T T C A T G C C C G G ; probe, 6-FAM-T C C A A T C A C G G C C T T G C C A-
T C T C -TAMRA; Mef2C forward, G G C T C T G T A A C T G G C T G G C A ; reverse, 
T C C C A A C T G A C T G A G G G C A G ; probe, 6-FAM-C A G C A G C A C C T A C A T A-
A C A T G C C G C C -TAMRA; TGF-β2 forward, C C C C T G C T A C T G C A A G T C A G ; 
reverse, G T C C T C A G G T C C T G C C T C C T ; probe, 6-FAM-C T T C T T G G C A C T-
G C G C T G T C T C G C -TAMRA; and endogenous control 18S RNA forward, 
C G C C G C T A G A G G T G A A A T T C ; reverse, T G G G C A A A T G C T T T C G C T C ; 
and probe, 6-FAM-T G G A C C G G C G C A A G A C G G A C -TAMRA. All remain-
ing primer probe sets were ordered as TaqMan Gene Expression Assays 
from Applied Biosystems (calmodulin, FHL2, myomesin, Nbr1, Sqstm1, 
and T-cap). Real-time PCR ampliﬁ cation reaction was performed on a Se-
quence Detection System (7900 HT; Applied Biosystems) using the qPCR 
 MasterMix Plus (Eurogentec) according to the manufacturer’s instructions 
with 2× TaqMan universal PCR master mix, 900 nM of primers, and 
250 nM of probe.
Thermal cycling conditions were as follows: 50°C for 2 min, 95°C 
for 10 min followed by 59 cycles of 95°C for 10 s, and 60°C for 1 min. 
Data were collected and analyzed with the Sequence Detection System 
2.1 software (Applied Biosystems). The comparative CT Method (∆∆CT 
Method) was used as described in the User Bulletin 2: ABI PRISM 7700 
 Sequence Detection System.
Statistical analysis
All results are expressed as means ± SD. An unpaired two-tailed t test was 
performed to assess differences between two groups. A P value of <0.05 
was considered signiﬁ cant.
Online supplemental material
Fig. S1 shows the morphology and contractile function of titin-deﬁ cient 
hearts. Fig. S2 provides the location of antibody epitopes and primer-
binding sites and shows expression changes in titin-deﬁ cient and wild-type 
animals. Fig. S3 shows increased apoptosis in knockout embryos that are 
secondary to the cardiac phenotype. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200601014/DC1.
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